Organon & Co (OGN)

NYSE HEALTHCARE
$13.32 +1.22% RSI 80 Overbought Add Alert

Moving Averages

SMA 200
$8.39
Price above

Company Profile

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$2.30B
P/E Ratio
12.26
EPS
$0.72
Beta
0.638
Dividend Yield
4.92%
52-Week High
$13.12
52-Week Low
$5.69

Similar stocks in DRUG MANUFACTURERS - GENERAL

Data last updated: April 11, 2026 at 7:22 PM EDT

Track OGN for free

Get e-mail RSI alerts when Organon & Co enters oversold or overbought territory. Free forever.

Add Alert